Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Wed, Dec 24th, 2025

Biotechnology Stocks

A list of publicly traded biotechnology and biotech-related stocks and ETFs.
Wed, Dec 24th, 2025

Biotechnology (biotech) Stocks are publicly traded companies that develop pharmaceutical drugs used in the treatment of disease. You can use Barchart's Biotech Stocks list to find investment opportunities and compare stocks involved in this hot industry.

View Profiles of these companies.

Biotechnology Stocks News

A $4.8 Billion Reason to Buy BioMarin Stock Today

BioMarin stock soars as the biotech firm announces a $4.8 billion acquisition of Amicus Therapeutics. The transaction could push BMRN shares even higher in 2026.

FOLD : 14.21 (unch)
BMRN : 61.14 (+3.14%)
The 2 Riskiest Stocks Investors Are Betting On With Over 300% Upside

These biotech bets are only for investors who can stomach volatility.

EYPT : 18.38 (-2.49%)
IRD : 2.01 (-2.43%)
This Biotech Stock Has More Than Tripled in 2025, but Red Flags Are Waving

AnaptysBio (ANAB) has surged 227% over the past year, hitting a 5-year high. Shares have strong technical momentum and a 100% “Buy” opinion from Barchart. Analyst sentiment remains bullish, but Wall...

ANAB : 50.04 (-0.58%)
2 ‘Strong Buy’ Biotech Stocks With 208% to 329% Upside Potential

These two biotech disruptors are poised for triple-digit breakout gains.

KYTX : 8.88 (+9.23%)
JANX : 14.12 (+0.21%)
$SPX : 6,909.79 (+0.46%)
This Hot Biotech Stock Just Set New All-Time Highs

BridgeBio Pharma (BBIO) has surged 145% over the past year, reaching an all-time high of $75.10. BBIO maintains a strong technical profile with a 100% “Buy” Barchart opinion. Revenue is projected to...

BBIO : 76.40 (-0.90%)
A Short Squeeze Could Send This Little-Known Biotech Stock Soaring

Spyre Therapeutics (SYRE) has strong technical momentum and is trading at a new 52 week high. SYRE maintains a 100% “Buy” opinion from Barchart. Shares are up more than 50% in the past month. High...

SYRE : 33.23 (-2.84%)
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar